recent articles

Presenters: Anindita Bhoumik, M.S., Scientist, R&D, ViaCyte, Inc. Jeff Dzubay, Ph.D., Field Application Scientist, Definiens Douglas Bowman, Associate Scientific Fellow, Takeda Pharmaceuticals International Co. Broadcast...

 Continues Leadership in Simplifying Tissue Image Analysis and Improving Workflow Efficiency MUNICH -- Definiens, the global leader in Tissue Phenomics® for oncology diagnostics announced the newest version of its leading image...

Big news this morning with acquisition of Definiens by MedImmune, strengthening MedImmune's focus on the discovery of novel predictive biomarkers in immune-oncology. Good news for patients and their providers. Tuesday, 4 November 2014 -...

Visit Definiens at booth #213 at the SITC Annual Meeting  to learn how Definiens’ image analysis solutions are being used in the SITC-led effort to validate The Immunoscore™ as a prognostic biomarker for colon cancer. At the conference we...

Alongside genomics, Tissue Phenomics™ is a key driver in the growth of personalized medicine and the improvement of patient lives. The unique ability of Tissue Phenomics’ to extract detailed quantitative data from tissue images and...

OR

platinum partners

gold partners

Silver Partners

Media Partners